Sonnet BioTherapeutics Holdings's market cap is currently ―. The company's EPS TTM is $-12.913; its P/E ratio is -0.14; Sonnet BioTherapeutics Holdings is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.70. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 18.60K	$ -10.55K	$ 36.85K	$ 36.45K	$ 37.26K
Gross Profit	$ 18.63K	$ -10.55K	$ 36.85K	$ 36.45K	$ 37.26K
EBIT	$ -1.17M	$ -3.72M	$ -3.95M	$ 5.74M	$ -5.54M
EBITDA	$ -1.15M	$ -3.71M	$ -3.93M	$ 5.75M	$ -5.52M
Net Income Common Stockholders	$ -1.17M	$ -3.72M	$ -3.95M	$ 5.74M	$ -5.54M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 3.00M	$ 2.27M	$ 7.02M	$ 11.40M	$ 1.70M
Total Assets	$ 5.34M	$ 5.43M	$ 10.03M	$ 13.31M	$ 4.94M
Total Debt	$ 186.69K	$ 203.91K	$ 220.63K	$ 237.61K	$ 238.79K
Net Debt	$ -2.81M	$ -2.07M	$ -6.80M	$ -11.16M	$ -1.46M
Total Liabilities	$ 2.77M	$ 5.66M	$ 6.62M	$ 7.94M	$ 8.48M
Stockholders Equity	$ 2.57M	$ -225.98K	$ 3.42M	$ 5.37M	$ -3.54M
Cash Flow	-
Free Cash Flow	$ -3.09M	$ -4.56M	$ -6.17M	$ -4.70M	$ -5.92M
Operating Cash Flow	$ -3.09M	$ -4.56M	$ -6.17M	$ -4.70M	$ -5.92M
Investing Cash Flow	-	$ -170.00K	$ -12.00K	$ -261.25K	-
Financing Cash Flow	$ 3.84M	$ -17.70K	$ 1.81M	$ 14.65M	$ 4.56M

Currency in USD

Sonnet BioTherapeutics Holdings Earnings and Revenue History

Income Statement >

Sonnet BioTherapeutics Holdings Debt to Assets

Balance Sheet >

Sonnet BioTherapeutics Holdings Cash Flow

Cash Flow >

Sonnet BioTherapeutics Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing